The US Food and Drug Administration (FDA) on Wednesday finalized guidance for sponsors on interacting with the agency on complex innovative trial designs (CID) for drugs and biologics. The nine-page ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results